Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the first tranche acquisition of certain operating assets from Veneto Holdings, L.L.C. ("Veneto") and certain of its affiliated entities (collectively, the "Veneto Group").
Healthcare / Pharmaceuticals / MedTech / Lifescience
Veneto Holdings, LLC
Generex Biotechnology Corporation